Načítá se...
Sofosbuvir and Ledipasvir for HIV/HCV Co-infected Patients
INTRODUCTION: Hepatitis C virus (HCV) is a chronic infection that disproportionately impacts people living with HIV. In the past, HCV therapy was less effective in individuals with HIV co-infection. However, the advent of direct-acting antivirals has revolutionized HCV treatment with high rates of s...
Uloženo v:
| Vydáno v: | Expert Opin Pharmacother |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4930150/ https://ncbi.nlm.nih.gov/pubmed/26898158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14656566.2016.1157580 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|